Episode 8

Diverse AI with Rajvir Madan

The diverse applications of artificial intelligence are transforming industries at an unprecedented pace, but with great breakthroughs come complex challenges.

Today I’m joined by Rajvir Madan, Chief Digital and Technology Officer at Arcutis Biotherapeutics, to break down the transformative impact AI is having in our field. 

Our discussion spans from the reduction of drug discovery timelines to addressing ethical concerns related to data biases. We also confront challenges tied to data quality and the implications for the workforce in the era of AI.

To grasp the full spectrum of AI’s influence on biotech and the vision it’s charting for our future, tune in for a compelling episode.

Specifically, this episode highlights the following themes:

  • Dissecting AI’s impact on biotech 
  • AI benefits, cautious of challenges and ethics
  • Addressing challenges in digital transformation for businesses

Links from this episode:

==== Time Stamps ====

00:00 – Introduction 

00:40 – About Rajvir Madan

05:41 – Ensure accurate, reliable data for model refinement

07:48 – Companies leveraging genetic data to improve AI models

09:53 – Underutilized medical data sets need proper mining

13:01 – Engineer emphasizes a problem-focused approach to AI

19:10 – Generative AI hype may not be necessary

20:34 – Simplified definition of generative AI and models

24:21 – Technology trends: AI, AR, VR, metaverse, quantum computing

28:07 – Growing up Indian, learning self-advocacy, promoting diversity

32:54 – Caution is needed with the rapid growth of technology

Go to Top